As of 2023, Japan imported 11.24 thousand kilograms of penicillins or streptomycins not in dosage forms. The projections for 2024 to 2028 show a steady increase in imports from 11.44 to 12.25 thousand kilograms, reflecting a yearly growth rate of approximately 1.75%. This suggests a consistent demand and reliance on these critical pharmaceuticals, with a five-year compound annual growth rate (CAGR) of nearly 1.75%.

Future trends to watch for:

Changes in global supply chains and manufacturing capacities impacting production and import trends.
Updates in regulations and policies can influence demand and pricing.
Developments in alternative antibiotics or treatments may alter the market landscape.